We are live on ! Find out more
ACM

Aster Capital Management Portfolio holdings

AUM $306M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
+$30.4M
Cap. Flow
+$30.3M
Cap. Flow %
13.29%
Top 10 Hldgs %
31.68%
Holding
1,487
New
557
Increased
199
Reduced
298
Closed
433

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.18M
2
ABT icon
Abbott
ABT
+$2.92M
3
HCA icon
HCA Healthcare
HCA
+$2.86M
4
WFC icon
Wells Fargo
WFC
+$2.72M
5
BAC icon
Bank of America
BAC
+$2.5M

Sector Composition

Rank Sector Weight
1 Technology 21.46%
2 Financials 12.13%
3 Industrials 10.93%
4 Healthcare 10.36%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSGR icon
976
Distribution Solutions Group
DSGR
$1.61B
$1.62K ﹤0.01%
+59
New +$1.66K
XENE icon
977
Xenon Pharmaceuticals
XENE
$6.22B
$1.61K ﹤0.01%
36
-923
-96% -$38.8K
GNL icon
978
Global Net Lease
GNL
$1.82B
$1.61K ﹤0.01%
+187
New +$1.5K
GEF.B icon
979
Greif Class B
GEF.B
$4.23B
$1.57K ﹤0.01%
+21
New +$1.39K
GLNG icon
980
Golar LNG
GLNG
$5.11B
$1.56K ﹤0.01%
42
-539
-93% -$20.6K
GABC icon
981
German American Bancorp
GABC
$1.92B
$1.53K ﹤0.01%
39
-56
-59% -$2.21K
ZBIO
982
Zenas BioPharma
ZBIO
$2.01B
$1.52K ﹤0.01%
42
-297
-88% -$9.77K
SION
983
Sionna Therapeutics
SION
$2.14B
$1.52K ﹤0.01%
37
-372
-91% -$14.1K
EVCM icon
984
EverCommerce
EVCM
$2.1B
$1.5K ﹤0.01%
124
-673
-84% -$7.15K
AVBP icon
985
ArriVent BioPharma
AVBP
$1.43B
$1.47K ﹤0.01%
+73
New +$1.52K
JBIO
986
Jade Biosciences
JBIO
$1.32B
$1.47K ﹤0.01%
+95
New +$1.11K
GNW icon
987
Genworth Financial
GNW
$3.71B
$1.42K ﹤0.01%
+157
New +$1.37K
ABUS icon
988
Arbutus Biopharma
ABUS
$913M
$1.41K ﹤0.01%
292
-1,669
-85% -$7.5K
HLMN icon
989
Hillman Solutions
HLMN
$1.81B
$1.39K ﹤0.01%
+160
New +$1.44K
INBX icon
990
Inhibrx
INBX
$1.23B
$1.34K ﹤0.01%
+17
New +$1.16K
LADR
991
Ladder Capital
LADR
$1.2B
$1.33K ﹤0.01%
121
-625
-84% -$6.79K
STRA icon
992
Strategic Education
STRA
$1.89B
$1.28K ﹤0.01%
+16
New +$1.28K
MTX icon
993
Minerals Technologies
MTX
$2.4B
$1.28K ﹤0.01%
+21
New +$1.24K
HUBG icon
994
HUB Group
HUBG
$2.91B
$1.28K ﹤0.01%
+30
New +$1.14K
SBSI icon
995
Southside Bancshares
SBSI
$973M
$1.28K ﹤0.01%
+42
New +$1.23K
UVE icon
996
Universal Insurance Holdings
UVE
$1.23B
$1.25K ﹤0.01%
+37
New +$1.18K
FLGT icon
997
Fulgent Genetics
FLGT
$526M
$1.21K ﹤0.01%
+46
New +$1.19K
CTBI icon
998
Community Trust Bancorp
CTBI
$1.43B
$1.19K ﹤0.01%
21
-48
-70% -$2.65K
IONS icon
999
Ionis Pharmaceuticals
IONS
$9.01B
$1.19K ﹤0.01%
+15
New +$1.13K
OPTU
1000
Optimum Communications Inc
OPTU
$307M
$1.02K ﹤0.01%
618
-967
-61% -$1.97K

Similar funds

Aster Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Aster Capital Management held 1,487 positions worth $228M, up 15% from $198M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Aster Capital Management deployed $30.3M of net new capital in Q4 2025, opening 557 new positions and adding to 199 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 49,113 shares worth $9.41M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Pultegroup, an estimated $1.87M trimmed.

  • Aster Capital Management's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 49,113 shares worth $9.41M.
  • Aster Capital Management added most to Broadcom in Q4 2025, an estimated $15.8M increase.
  • Aster Capital Management's biggest Q4 2025 reduction was Pultegroup, cutting an estimated $1.87M.
  • Aster Capital Management fully exited Johnson & Johnson in Q4 2025, selling an estimated $4.18M.
  • Aster Capital Management's ten largest holdings make up 32% of its $228M portfolio in Q4 2025.
  • Aster Capital Management opened 557 new positions and closed 433 in Q4 2025.
  • Aster Capital Management's portfolio value rose 15% quarter-over-quarter to $228M.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.